Dr Judy Chou, CEO, President and Board Member of AltruBio, Inc, explains how agonist antibodies show potential as a novel therapeutic approach in immunological diseases.

The glaucoma drug methazolamide removed tau build-up and lessened signs of dementia in genetically-engineered zebrafish and mice.

Researchers have uncovered a how INPP4B, alongside PIKfyve and TRPML-1, drives pancreatic cancer metastasis. Researchers at the University of Toronto, Toronto Metropolitan University and the Princess ...

The Women in Advanced Therapies pre-day at Advanced Therapies Europe 2024 provided a great forum to address investment in diversity and elevating female leadership. Following this, we spoke to Clare ...

Small molecules are essential for developing effective medicines, but their structural complexity and material behaviour present difficulties. In this article, Chris Brown, Senior Chemist, Onyx ...